Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 481 AL 495

Case report: a unique presentation of memantine overdose causing echolalia and hypertension

Durrani S, Ahmed S.

BMC Geriatr. 2024 Feb 1;24(1):123. doi: 10.1186/s12877-024-04658-2.

Intriguing review and topics in this month of Hypertension Research

Hoshide S, Mogi M, Kario K.

Hypertens Res. 2024 Feb;47(2):253-254. doi: 10.1038/s41440-023-01532-3. Epub 2024 Feb 5.

Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer's disease

Zuliani G, Zuin M, Romagnoli T, Polastri M, Cervellati C, Brombo G.

Aging Clin Exp Res. 2024 Feb 7;36(1):23. doi: 10.1007/s40520-023-02675-6.

Repurposing Erectile Dysfunction Medication for Alzheimer Disease Prevention

Yasar S, Nidadavolu L.

Neurology. 2024 Feb 27;102(4):e209180. doi: 10.1212/WNL.0000000000209180. Epub 2024 Feb 7.

Unveiling the role of astrocytes in postoperative cognitive dysfunction

He L, Duan X, Li S, Zhang R, Dai X, Lu M.

Ageing Res Rev. 2024 Mar;95:102223. doi: 10.1016/j.arr.2024.102223. Epub 2024 Feb 5.

Anti-Amyloid Therapies for Alzheimer's Disease: An Alzheimer Europe Position Paper and Call to Action

Bradshaw AC, Georges J.

J Prev Alzheimers Dis. 2024;11(2):265-273. doi: 10.14283/jpad.2024.37.

Nanolithium, a New Treatment Approach to Alzheimer's Disease: A Review of Existing Evidence and Clinical Perspectives

Guilliot S, Wilson EN, Touchon J, Soto ME.

J Prev Alzheimers Dis. 2024;11(2):428-434. doi: 10.14283/jpad.2024.26.

Latest advances and clinical application prospects of resveratrol therapy for neurocognitive disorders

Pei MQ, Xu LM, Yang YS, Chen WC, Chen XL, Fang YM, Lin S, He HF.

Brain Res. 2024 May 1;1830:148821. doi: 10.1016/j.brainres.2024.148821. Epub 2024 Feb 23.

Advances in nanoprobes for molecular MRI of Alzheimer's disease

Parekh P, Badachhape AA, Tanifum EA, Annapragada AV, Ghaghada KB.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr;16(2):e1946. doi: 10.1002/wnan.1946.

Comparative Efficacy and Safety of Monoclonal Antibodies for Cognitive Decline in Patients with Alzheimer's Disease: A Systematic Review and Network Meta-Analysis

Qiao Y, Gu J, Yu M, Chi Y, Ma Y.

CNS Drugs. 2024 Mar;38(3):169-192. doi: 10.1007/s40263-024-01067-2. Epub 2024 Mar 1.

Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease

Balakrishnan R, Jannat K, Choi DK.

Redox Biol. 2024 May;71:103105. doi: 10.1016/j.redox.2024.103105. Epub 2024 Mar 4.

Recent Aspects of Periodontitis and Alzheimer's Disease-A Narrative Review

Cichońska D, Mazuś M, Kusiak A.

Int J Mol Sci. 2024 Feb 23;25(5):2612. doi: 10.3390/ijms25052612.

Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits

Katariya RA, Sammeta SS, Kale MB, Kotagale NR, Umekar MJ, Taksande BG.

Ageing Res Rev. 2024 Apr;96:102269. doi: 10.1016/j.arr.2024.102269. Epub 2024 Mar 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias